Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Osteoprotegerin (human) ELISA kit

 
ALX-850-280A-KI01 96 wells 1,282.00 USD
Do you need bulk/larger quantities?
 
Replaces Prod. #: ALX-850-280

The Osteoprotegerin (human) ELISA kit is a complete, colorimetric, immunometric immunoassay kit for the quantitative determination of osteoprotegerin in plasma and serum with results in just ~5 hours.

Product Specification

Alternative Name:OPG, TNFRSF 11B, Tumor Necrosis Factor receptor superfamily member 11B, Osteoclastogenesis Inhibitory Factor, OCIF
 
Sensitivity:1.4pg/ml (range 0 to 500pg/ml)
 
Assay Time:~5 hours
 
Applications:ELISA, Colorimetric detection
 
Application Notes:For the quantitative determination of human osteoprotegerin in serum and plasma.
 
Species reactivity:Human
 
Quantity:96 wells (~80 tests).
 
Shipping:Blue Ice Not Frozen
 
Long Term Storage:+4°C
 
Kit/Set Contains:Plate pre-coated with capture antibody, Wash buffer, Detection antibody, Standards, Control, Assay buffer, Conjugate Streptavidin-HRP, TMB solution, Stop solution
 
Scientific Background:Osteoprotegerin (OPG) or osteoclast inhibitory factor (OCIF) is a glycoprotein of the TNF receptor superfamily 11b (gene name TNFRSF11B). OPG is synthesized as a monomer of 380 amino acids and is assembled as a homodimer within the cell, and then secreted mainly as a disulfide-linked homodimer into the extracellular compartment. OPG is produced by many different tissues and cell types including osteoblasts. OPG is a negative regulator of bone resorption by acting as decoy receptor for RANKL, thus neutralizing its function in osteoclastogenesis. This glycoprotein is also involved in the regulation of vascular calcification.
 
UniProt ID:O00300
 

Product Literature References

Activation of the p53 pathway down-regulates the osteoprotegerin (OPG) expression and release by vascular endothelial cells: P. Secchiero, et al.; Blood 111, 1287 (2008), Abstract;
Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo: G. Zauli, et al.; Blood 110, 536 (2007), Abstract;
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction: P. Secchiero, et al.; Am. J. Pathol. 169, 2236 (2006), Abstract; Full Text

Product Toolbox

PRODUCT RESOURCES

Datasheet
MSDS
Certificate of Analysis
Manual

RELATED PRODUCTS

By target:
Osteoprotegerin
By biological activity:
Osteoprotegerin Immunoassay kit
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Related Literature

Catalogs
Immunoassay Kits
Immunoassay Kits
Download as PDF

All new literature pieces

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,